Moderna (MRNA) up 70% premarket on positive phase 3 results of first mRNA treatment to prevent cancer (melanoma recurrence)
Truly groundbreaking stuff
“An experimental mRNA-based vaccine succeeded in preventing cancer from coming back or spreading in a study of high-risk melanoma patients, Moderna and its partner Merck said Wednesday, paving the way for a potentially new life-extending treatment for the thousands of people diagnosed with the deadly skin cancer each year.”
MRNA up 70% as of this post, MRK up 10%